×


 x 

Shopping cart
Jeffrey S. Albert - Pharmacologic Treatments for Schizophrenia - 9780470322826 - V9780470322826
Stock image for illustration purposes only - book cover, edition or condition may vary.

Pharmacologic Treatments for Schizophrenia

€ 215.73
FREE Delivery in Ireland
Description for Pharmacologic Treatments for Schizophrenia Hardcover. * Covering a wide range of receptors and molecular targets, this book provides a comprehensive resource for neuro-drug discovery and molecular targets for schizophrenia. Editor(s): Wood, Michael W. Num Pages: 486 pages, Illustrations. BIC Classification: MJ; MM; PN; PS. Category: (P) Professional & Vocational. Dimension: 240 x 165 x 31. Weight in Grams: 816.

New and emerging directions in pharmaceutical research to better treat schizophrenia

Although the dopamine hypothesis has been the cornerstone of schizophrenia therapeutics, it is clear that dopamine-based approaches do not treat all aspects of the disease. Moreover, many schizophrenia patients fail to respond to current antipsychotics. Integrating chemistry, biology, and pharmacology, this book explores emerging directions in pharmaceutical research for drug targeting and discovery in order to find more effective treatments for schizophrenia, one of the most serious and widespread psychiatric diseases.

Targets and Emerging Therapies for Schizophrenia presents the basics of schizophrenia, drug targets for the disease, and potential ... Read more

With contributions from an international team of pioneering pharmaceutical researchers, this book compiles the current knowledge in the field, setting the stage for new breakthroughs in the treatment of schizophrenia. Targets and Emerging Therapies for Schizophrenia:

  • Provides a comprehensive resource for neuro-drug discovery and the development of molecular targets for schizophrenia treatment
  • Draws from chemistry, biology, and pharmacology for more effective drug targeting and discovery
  • Explores a wide range of receptors and molecular targets, including dopamine, PDEs, and neuropeptides

With Targets and Emerging Therapies for Schizophrenia as their guide, drug discovery and development scientists have the information they need to advance their own research so that new, more effective treatments for schizophrenia will soon be a reality.

Show Less

Product Details

Format
Hardback
Publication date
2012
Publisher
John Wiley and Sons Ltd United Kingdom
Number of pages
486
Condition
New
Number of Pages
486
Place of Publication
New York, United States
ISBN
9780470322826
SKU
V9780470322826
Shipping Time
Usually ships in 7 to 11 working days
Ref
99-50

About Jeffrey S. Albert
JEFFREY S. ALBERT, PhD, is a Project Leader and Head of Lead Generation Chemistry in AstraZeneca's neuroscience department. He has authored or coauthored more than forty publications, mostly focusing on novel therapeutic targets involved in depression, schizophrenia, and Alzheimer's disease and on the development and application of fragment-based lead generation methodologies. MICHAEL W. WOOD, PhD, is an External ... Read more

Reviews for Pharmacologic Treatments for Schizophrenia
“In summary, this book provides a timely and convenient reflection on schizophrenia drug discovery and development, which has been a major component of psychiatric drug research for several decades.”  (ChemMedChem, 1 March 2013)  

Goodreads reviews for Pharmacologic Treatments for Schizophrenia


Subscribe to our newsletter

News on special offers, signed editions & more!